A carregar...

MYC Inhibition depletes cancer stem-like cells in triple-negative breast cancer

There is mounting evidence that cancer stem-like cells (CSCs) are selectively enriched in residual tumors after anticancer therapies which may account for tumor recurrence and metastasis by regenerating new tumors. Thus, there is a critical need to develop new therapeutic agents that can effectively...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Res
Main Authors: in Yang, Aim, Qin, Shenghui, Schulte, Bradley A., Ethier, Stephen P., Tew, Kenneth D., Wang, Gavin Y.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5712265/
https://ncbi.nlm.nih.gov/pubmed/28951456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-16-3452
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!